Heme Oxygenase-1-Targeted Cancer Therapy: At the Crossroads of Cytoprotection and Tumour Progression

Introduction. HO-1 is a stress-responsive enzyme involved in cellular protection against oxidative damage, inflammation, and tissue injury. However, in cancer, its cytoprotective functions may paradoxically support cancer progression, immune evasion, and therapy resistance. Material and methods. This review explores current findings on HO-1’s dual role in cancer biology. We analysed studies addressing its function in redox regulation, angiogenesis, immune modulation, iron metabolism, and its impact on treatment response. Particular focus was placed on HO-1’s downstream metabolites (CO, biliverdin/bilirubin, and iron) and their influence on tumour development. Results. HO-1 contributes to cellular defence by limiting reactive oxygen species and supporting DNA repair. However, its overexpression in tumours promotes survival signalling, angiogenesis (via VEGF and HIF-1α), metabolic reprogramming, and resistance to apoptosis and chemotherapy. Additionally, HO-1 regulates ferroptosis by modulating intracellular iron and lipid peroxidation. The Nrf2/HO-1 axis is frequently upregulated in tumours, enhancing antioxidant capacity and undermining therapeutic efficacy. Preclinical studies show that HO-1 inhibition—via gene silencing, small molecules, or combination with chemotherapy and photodynamic therapy—can restore treatment sensitivity and suppress tumour growth. Conclusions. HO-1 plays a context-dependent, dual role in cancer as both a protector and promoter. Therapeutic targeting of HO-1 holds promise but requires precision to avoid disrupting its protective roles in normal tissues. Further research should aim to develop selective, tumour-specific HO-1 inhibitors and integrate them into combination treatment strategies.

• Publication year

  2025

• Venue

  Journal of Medical Sciences

• Publication date

  2025-09-25

• Fields of study

  Not labeled

• Identifiers
  DOI 10.20883/medical.e1358
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Protective effect of andrographolide against ulcerative colitis by activating Nrf2/HO-1 mediated antioxidant response

  2024cited by this paper
• Cytoprotective Role of Heme Oxygenase-1 in Cancer Chemoresistance: Focus on Antioxidant, Antiapoptotic, and Pro-Autophagy Properties

  2023cited by this paper
• Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma

  2021cited by this paper
• Heme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions

  2021cited by this paper
• Nrf2/HO-1 Axis Regulates the Angiogenesis of Gastric Cancer via Targeting VEGF

  2021cited by this paper
• Inhibition of Nrf2/HO-1 signaling pathway by Dextran Sulfate suppresses angiogenesis of Gastric Cancer

  2021cited by this paper
• The Role of HO-1 and Its Crosstalk with Oxidative Stress in Cancer Cell Survival

  2021cited by this paper
• The Diverse Roles of Heme Oxygenase-1 in Tumor Progression

  2021cited by this paper
• Heme Oxygenase-1 in Central Nervous System Malignancies

  2020cited by this paper
• PI3K/Akt pathway-mediated HO-1 induction regulates mitochondrial quality control and attenuates endotoxin-induced acute lung injury

  2019cited by this paper
• Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application.

  2019cited by this paper
• Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib

  2018cited by this paper
• A Dual Role of Heme Oxygenase-1 in Cancer Cells

  2018cited by this paper
• Low heme oxygenase-1 expression promotes gastric cancer cell apoptosis, inhibits proliferation and invasion, and correlates with increased overall survival in gastric cancer patients.

  2017cited by this paper
• Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death

  2015cited by this paper
• The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance

  2015cited by this paper
• Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway

  2014cited by this paper
• Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin.

  2014cited by this paper
• Cigarette smoke induces nuclear translocation of heme oxygenase 1 (HO-1) in prostate cancer cells: Nuclear HO-1 promotes vascular endothelial growth factor secretion

  2013cited by this paper
• Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth.

  2013cited by this paper
• Crucial Role of Heme Oxygenase-1 on the Sensitivity of Cholangiocarcinoma Cells to Chemotherapeutic Agents

  2012cited by this paper
• An Anti-Inflammatory Role for Carbon Monoxide and Heme Oxygenase-1 in Chronic Th2-Mediated Murine Colitis

  2011cited by this paper
• Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.

  2011cited by this paper
• Heme oxygenase-1 and carbon monoxide modulate DNA repair through ataxia-telangiectasia mutated (ATM) protein

  2011cited by this paper
• Mechanisms of cell protection by heme oxygenase-1.

  2010cited by this paper
• The biliverdin-bilirubin antioxidant cycle of cellular protection: Missing a wheel?

  2010cited by this paper
• A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer.

  2009cited by this paper
• Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib.

  2008cited by this paper
• Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice

  2008cited by this paper
• Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications.

  2006cited by this paper
• Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity

  2006cited by this paper
• Inhibition of Heme Oxygenase-1 Increases Responsiveness of Pancreatic Cancer Cells to Anticancer Treatment

  2005cited by this paper
• Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network.

  2004cited by this paper
• Heme oxygenase 1 is required for mammalian iron reutilization.

  1997cited by this paper
• Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide.

  1995cited by this paper

• No citing papers are available for this paper.